AACR Annual Meeting

The multi-day programme spans population science and prevention, cancer biology, translational research, clinical studies, survivorship, and advocacy—creating a single venue to track emerging discoveries, translational progress, and practice-relevant insights. Alongside the scientific programme, the meeting includes a large exhibition and extensive opportunities for collaboration and networking.

Who the audience is and how many attend

Audience

• Cancer researchers across academia, biotech and pharma
• Clinicians and clinical investigators, including trialists and translational teams
• Healthcare professionals involved in oncology care and research
• Patients, survivors and advocates engaged in research and policy dialogue
• Industry partners and solution providers supporting oncology R&D

Scale

• A large, multi-day international congress with a substantial scientific programme (including abstracts/posters) and a major exhibitor presence.
• The organiser does not consistently publish a single fixed headline figure for total attendees, exhibitors/vendors, or main sponsors on the main meeting overview pages.

What to expect

• A broad, high-impact scientific programme covering discovery, translational and clinical cancer research
• Abstract-driven sessions and poster presentations highlighting new data and emerging approaches
• Dedicated professional development and methods-oriented content alongside plenary and symposium sessions
• High-density networking across academia, clinical research and industry, plus access to a sizeable exhibition floor